Latest Headlines

  1. Qosina Is The One-Stop Source For Tuohy Borst Adapters 10/3/2019

    Qosina is pleased to carry over 40 different configurations of tuohy borst adapters in sizes ranging from 0-18 FR.

  2. Dance Biopharm Rebrands, Now Aerami Therapeutics 9/25/2019

    Dance Biopharm, a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, today announced it is rebranding as Aerami Therapeutics and moving its headquarters to Durham, North Carolina.

  3. MKS Announces Ophir® Large Aperture Laser Power/Energy Sensor For Pulsed Lasers 9/12/2019

    MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced the Ophir® L2000W-PF-120 Laser Power/Energy Sensor, a water-cooled sensor for measuring large pulsed lasers. The thermal sensor measures powers from 1W to 2000W and energies from 6J to 6000J over the spectral range of 0.3µm to 2.2µm. The L2000W-PF-120 features a large 120mm aperture to accommodate high energy densities and short pulses. A fast, 7 sec response time balances the need to measure fast drifts and instabilities with the ability to handle high energy levels.

  4. Protolabs Adds Carbon Technology To Its 3D Printing Service 9/10/2019

    Digital manufacturer Protolabs (NYSE: PRLB) has added the Carbon platform to its portfolio of production-grade additive manufacturing technologies. With Carbon Digital Light Synthesis™ (DLS), Protolabs’ customers can move into production faster and more cost-efficiently than ever before with 3D printing.

  5. Qosina President And CEO Scott Herskovitz Joins CEWIT Medical Advisory Board At Stony Brook University 9/9/2019

    Qosina is pleased to announce that Scott Herskovitz, President and CEO, has joined the Medical Advisory Board (MAB) of the Center of Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University.

  6. FDA Grants Breakthrough Designation To SoniVie’s TIVUS System To Treat Pulmonary Arterial Hypertension 9/6/2019

    SoniVie, an Israeli company developing a novel system for the treatment of PAH, today announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the Therapeutic Intra-Vascular Ultrasound (TIVUS) System in patients with PAH.

  7. Innovenn Launches New Human Factors Business Under The Name Improvita And Opens New State Of The Art Testing Lab 9/4/2019

    Innovenn, a leader in Digital Therapeutics, has separated its human factors testing business under a new name Improvita which means; To Improve Life.  Innovenn will now focus purely on digital health care solutions including digital therapeutics and other software to help diagnose, prognose and manage patient care for those with rare diseases. Improvita will focus on human factors testing, ethnographics, user interface testing and user experience testing for medical devices, software as a medical device and combination drug / medical device products. To support the growing business, Improvita also opened a new state of the art testing lab in Madison, Wisconsin.

  8. Orchestra BioMed’s Cardiac Neuromodulation Therapy Device For Hypertension Earns CE Mark 9/4/2019

    Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced today that it has received CE Mark approval for its Moderato® implantable pulse generator system that delivers BackBeat Cardiac Neuromodulation Therapy™ (CNT) for treatment of hypertension while also providing standard pacemaker functions.

  9. Qosina Carries A New Line Of Securing Clamps For High-Pressure Connections 9/4/2019

    Qosina is pleased to stock a variety of Oetiker stainless steel, non-greased StepLess ear clamps that can be used in a wide range of applications across multiple industries. These clamps are ideal for high-pressure connections where leakage is a concern, providing a more secure connection than standard plastic securing clamps.

  10. Oval Medical Technologies Moves To New Location In Cambridge Research Park To Support Pharmaceutical Partners’ Advanced Drug-Delivery Needs 8/27/2019

    Oval Medical Technologies Limited (Oval), a leader of patient-centric autoinjectors, has signalled a new stage in its growth with a move to a purpose-designed facility in Cambridge Research Park, U.K.